BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12540018)

  • 1. Inhibition of antigen-induced arthritis in guinea pigs by a selective LTB4 receptor antagonist LY293111Na.
    Kuwabara K; Jyoyama H; Fleisch JH; Hori Y
    Inflamm Res; 2002 Nov; 51(11):541-50. PubMed ID: 12540018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of leukotriene B4 receptor antagonist, LY293111Na, on antigen-induced bronchial hyperresponsiveness and leukocyte infiltration in sensitized guinea pigs.
    Asanuma F; Kuwabara K; Arimura A; Furue Y; Fleisch JH; Hori Y
    Inflamm Res; 2001 Mar; 50(3):136-41. PubMed ID: 11339501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the second-generation leukotriene B(4) receptor antagonist, LY293111Na, on leukocyte infiltration and collagen-induced arthritis in mice.
    Kuwabara K; Yasui K; Jyoyama H; Maruyama T; Fleisch JH; Hori Y
    Eur J Pharmacol; 2000 Aug; 402(3):275-85. PubMed ID: 10958895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.
    Fretland DJ; Anglin CP; Bremer M; Isakson P; Widomski DL; Paulson SK; Docter SH; Djuric SW; Penning TD; Yu S
    Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studies.
    Silbaugh SA; Stengel PW; Cockerham SL; Froelich LL; Bendele AM; Spaethe SM; Sofia MJ; Sawyer JS; Jackson WT
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):397-404. PubMed ID: 10763854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
    Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
    J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of LY293111Na, a leukotriene B4 receptor antagonist, on the pulmonary neutrophilia and CD11b expression caused by inhalation of a leukotriene B4 aerosol in rhesus monkeys.
    Allen DL; Hoffman WP; Marder P; Matchett MR; Leiter PA; Abbott DL; Wolff RK
    J Pharmacol Exp Ther; 1996 Apr; 277(1):341-9. PubMed ID: 8613940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene B4-induced granulocyte trafficking in guinea pig dermis. Effect of second-generation leukotriene B4 receptor antagonists, SC-50605 and SC-51146.
    Fretland DJ; Widomski DL; Anglin CP; Penning TD; Yu S; Djuric SW
    Inflammation; 1993 Jun; 17(3):353-60. PubMed ID: 8392493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist.
    Marder P; Sawyer JS; Froelich LL; Mann LL; Spaethe SM
    Biochem Pharmacol; 1995 May; 49(11):1683-90. PubMed ID: 7786309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose methotrexate decreases intraarticular prostaglandin and interleukin 1 levels in antigen induced arthritis in rabbits.
    Novaes GS; Mello SB; Laurindo IM; Cossermelli W
    J Rheumatol; 1996 Dec; 23(12):2092-7. PubMed ID: 8970046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammation.
    Salmon JA; Simmons PM; Moncada S
    J Pharm Pharmacol; 1983 Dec; 35(12):808-13. PubMed ID: 6141244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LTB4-induced transient neutropenia in the rat: a model for evaluating efficacy and bioavailability of LTB4 receptor antagonists.
    Pellas TC; Colombo C; Fryer LR; Pastor G; Haston W; Raychaudhuri A; Kotyuk B; Greenspan PD; Healy C; DiPasquale G
    J Pharmacol Toxicol Methods; 1993 Nov; 30(3):137-42. PubMed ID: 8305713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of leukotriene B4 to airway inflammation and the effect of antagonists.
    Richards IM; Sun FF; Taylor BM; Shields SK; Griffin RL; Morris J; Wishka DG; Smith HW; Johnson RA; Dunn CJ
    Ann N Y Acad Sci; 1991; 629():274-87. PubMed ID: 1659282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arthritis induced immunologically with cationic amidated bovine serum albumin in the guinea pig. A morphological and biochemical study on the destruction of articular cartilage.
    Yamashita N; Nakanishi I; Okada Y
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(1):57-66. PubMed ID: 1673278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effect of FR140423, a novel selective cyclo-oxygenase-2 inhibitor, in rat adjuvant arthritis without gastrointestinal side effects.
    Ochi T; Goto T
    J Pharm Pharmacol; 2000 May; 52(5):553-60. PubMed ID: 10864144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermal inflammation in primates, mice, and guinea pigs: attenuation by second-generation leukotriene B4 receptor antagonist, SC-53228.
    Fretland DJ; Gokhale R; Mathur L; Baron DA; Paulson SK; Stolzenbach J
    Inflammation; 1995 Jun; 19(3):333-46. PubMed ID: 7628862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.
    Sarau HM; Foley JJ; Schmidt DB; Martin LD; Webb EF; Tzimas MN; Breton JJ; Chabot-Fletcher M; Underwood DC; Hay DW; Kingsbury WD; Chambers PA; Pendrak I; Jakas DR; Sathe GM; Van Horn S; Daines RA; Griswold DE
    Prostaglandins Leukot Essent Fatty Acids; 1999 Jul; 61(1):55-64. PubMed ID: 10477044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiinflammatory agent SC-41930 inhibits granulocyte infiltration of the rodent dermis induced by 6-trans-leukotriene B4.
    Fretland DJ; Widomski DL; Anglin CP; Gaginella TS
    Prostaglandins Leukot Essent Fatty Acids; 1991 Sep; 44(1):61-5. PubMed ID: 1658813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis.
    Grespan R; Fukada SY; Lemos HP; Vieira SM; Napimoga MH; Teixeira MM; Fraser AR; Liew FY; McInnes IB; Cunha FQ
    Arthritis Rheum; 2008 Jul; 58(7):2030-40. PubMed ID: 18576322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.